Article Text

other Versions

PDF
Adrenal suppression following intralesional corticosteroids for periocular haemangiomas
  1. C Morkane1,
  2. J W Gregory1,
  3. P Watts2,
  4. J T Warner2
  1. 1Cardiff University, Cardiff, UK
  2. 2University Hospital of Wales, Cardiff, UK
  1. Correspondence to Dr Justin Warner, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK; justin.warner{at}wales.nhs.uk

Abstract

Background/aims Treatment with intralesional triamcinolone/betamethasone is recommended for infantile sight-threatening periocular haemangiomas. This study investigates the endocrine and weight changes in 15 infants undergoing therapy over 12 years.

Methods 15 infants, median age 19 weeks (range 10–56) receiving intra/perilesional triamcinolone/betamethasone underwent serial measurement of weight, early morning serum cortisol and adrenocorticotropic hormone (ACTH) before and after injection.

Results Cortisol fell from a median (range) of 383 (112–594) to 28 (<10–506) nmol/l (p=0.005) and ACTH from 26 (14–134) to 9 (5–20) ng/l (p=0.05) from before injection to 4 weeks after treatment. Prolonged adrenal suppression occurred in 13 out of 15 cases with time to recovery being 19.5 (4–65) weeks. Failure to gain weight appropriately was observed in 14 infants but recovered once normal adrenal function was re-established.

Conclusion Prolonged adrenal suppression following triamcinolone/betamethasone injection for periocular haemangiomas is common and associated with faltering weight gain.

Statistics from Altmetric.com

Footnotes

  • Competing interest None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.